Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa2g02396 | ATGTCTCCCTCAAACTCAATGCTCAAAACCCTAATTTCTCTCTCTAAACTCTTCCTCTCTTTCTCTCTCCTCCTCCACACCGCCATTGCCGATGACGGTGTTTTCATGTCCAAGCTGGCCAAATCACTTTCACCAACTCCCTCAGGCTGGACCACGGCGACCACATTCTGCAGCTGGACCGGCGTGAAATGCGACGATTCTAACCGCGTTACGTCCATCAACGTACCTTCAAAGTCACTCACCGGAACTATACCTTCCGATCTGAACTCACTCTCTCAACTCACCTCCATCTCTTTCCAGTCCAACTCGCTCGCCGGCGCGTTACCTTCACTCGCTAATCTCTCTAATCTTCAGTCGGTTTTTCTCAGTAGTAACAACTTTACTTCAATCCCTGATGGTTGTTTTCAGGGTCTCACCAGTCTCCAGAAGCTTTCCATGACTGGAAACACCAACCTTAAACCATGGAGCTTTCCCTCTGAGTTGACTCAGTCTTTGAATCTCGTTGAACTCGACCTTGGTCAAACGAACCTTATAGGTTCCTTGCCGGATATATTCTCTCCATTGTTCAGTTTGCAGAACCTTCGTCTAGCTTACAACAATCTAACCGGAGATTTACCGAACTCGTTTTCAGGATCTGGGATTCAGAACCTGTGGCTCAACAATCAGCAAGATGGTTTCGGGTTCACTGGCTCTCTCGATTTGCTTTCTTCGATGTCTCATTTGACTCAAGTTTGGTTTCAGAAGAACAAGTTCACTGGTCCCATTCCTGATTTAACTAACTGTACTAATTTGTTTGATCTTCAGCTTCGTGATAATCAGTTAACGGGTGTTGTTCCGCCTTCTTTGATGAGTTTAGCTAGTTTGACCAACGTTTCATTGGATAACAATCATTTGCAGGGTCCTTTTCCTTCTTTTGGGAAACGTGTAAAGGTTGCTCCTAATGATGGGATCAATAGCTTTTGTAAAGACACTCCCGGACCTTGTGATCCCAGGGTTACTACTTTGCTTGATGTTGCTGCTGGTTTTGGGTATCCTCTTCAGTTGGCTACTTCTTGGATAAAGAATGATCCTTGTCAAGATTGGAGCTTTGTTTTGTGTTCAGGAGGGAAGATTATTACTGTGAATTTAGCTAAGCTGAACTTGAATGGAACTATTTCACCTGCATTTGGGCATTTAACTGATTTGAGGAATTTGTATCTGGGTGGTAACAACTTGTCTGGTTCCATACCGGGGAGCTTGACGGGTTTGACTCAACTTGAGGTTTTGGATGTGTCTAACAACAATCTATCCGGAGAGATTCCTAAATTCTCTACTAAAGTGAAGTTCAATTCTGCTGGTAATGCTTTGCTTGGGCCTTCTGGAGGCGATAGAGGAAAGGGAACTACTCCACCAGAGAGTTCTGGTGGTGCACCAAGTGGAAGTCCATCAGGAAAGTCAGGTGGTTCATCGCTGTCGCCTGCTTGGATCGCAGGTATAGCTGTTATTGCTGTGTTTTTTGTTGCAGTGGTGTTGTTTGTGTTTTGTAAGTGTTATACTAAGAATCGGAGGCATGGGGAATTCGGAAGGGTTAATAATCCTGAAAATGGAAAAGGTGAGGTTAAACTTGATGTCATGAGTGTTTCCAATTCTAATGGATATGGTGGAGTTCCAAGTGAGTTACAGAGTCAGGGAAGTGAGGGTAGTAACAACCTTCAGGTTTTTGAGGGTGGAAATGTTACTATTTCAATCCAAGTTCTTAGGCAAGTAACTGGTAATTTCAGTCAAGATAACATTTTGGGTAGGGGAGGATTTGGAGTTGTTTATAAAGGGGAATTGCATGATGGAACTAAGATTGCTGTGAAGAGGATGGAATCTGTTGCAGTGGGAACTAAGGGATTGAATGAGTTCCAAGCAGAGATTGCAGTTCTAACTAAAGTTAGGCATAGGCATTTGGTTGCTCTTTTAGGATTCTGCATTAACGGAAATGAAAGGCTTTTGGTGTATGAGTATATGCCTCAAGGAACATTAACACAACACCTGTTTGATTGGGGTGAAAACGGATGTGCTCCTTTGACTTGGAAACAAAGAGTAGCAATAGCTTTGGATGTTGCACGGGGAGTGGAATACTTGCACAGCTTAGCTCAGCAAAGCTTCATTCACAGGGACTTAAAACCCTCCAACATACTATTGGGTGATGACATGAGAGCAAAGGTTGCAGATTTTGGGTTGGTTAAAAATGCACCAGATGGGAAATATTCCGTTGAGACGAGGTTGGCAGGAACATTTGGATATTTGGCACCTGAATATGCAGCCACTGGAAGAGTAACAACCAAAGTAGATGTTTATGCATTTGGAGTAGTTCTGATGGAATTGATTACTGGTAGAAGGGCATTGGATGATACTATGCCTGATGAACGATCCCATTTGGTTTCATGGTTCCGCCGGGTACAAGTCAACAAGGAGAACATACCTAAAGCAATCGATCAAACATTGAACCCCGACGAAGAAACCATGGAGAGCATATATAAAGTGGCCGAGCTAGCAGGCCATTGCACTGCTCGCGAACCATACCAGAGGCCGGATATGGGACATGCAGTGAATGTTCTAGTTCCTCTGGTAGAGCAATGGAAGCCTACCAGTCATGAAGAAGAAGATGGTTATGGTATTGACCTTCACATGAGCCTCCCTCAAGCTTTGCAAAGATGGCAAGCCAATGAAGGCACTTCCCAAATGTTTAACGACACATCTTTCTCACAAACCCAATCAAGTATTCCTGCAAAACCTTCCGGATTCGCCGACTCCTTTGATTCAATGGATTGCCGATAA | 2805 | 0.4392 | MSPSNSMLKTLISLSKLFLSFSLLLHTAIADDGVFMSKLAKSLSPTPSGWTTATTFCSWTGVKCDDSNRVTSINVPSKSLTGTIPSDLNSLSQLTSISFQSNSLAGALPSLANLSNLQSVFLSSNNFTSIPDGCFQGLTSLQKLSMTGNTNLKPWSFPSELTQSLNLVELDLGQTNLIGSLPDIFSPLFSLQNLRLAYNNLTGDLPNSFSGSGIQNLWLNNQQDGFGFTGSLDLLSSMSHLTQVWFQKNKFTGPIPDLTNCTNLFDLQLRDNQLTGVVPPSLMSLASLTNVSLDNNHLQGPFPSFGKRVKVAPNDGINSFCKDTPGPCDPRVTTLLDVAAGFGYPLQLATSWIKNDPCQDWSFVLCSGGKIITVNLAKLNLNGTISPAFGHLTDLRNLYLGGNNLSGSIPGSLTGLTQLEVLDVSNNNLSGEIPKFSTKVKFNSAGNALLGPSGGDRGKGTTPPESSGGAPSGSPSGKSGGSSLSPAWIAGIAVIAVFFVAVVLFVFCKCYTKNRRHGEFGRVNNPENGKGEVKLDVMSVSNSNGYGGVPSELQSQGSEGSNNLQVFEGGNVTISIQVLRQVTGNFSQDNILGRGGFGVVYKGELHDGTKIAVKRMESVAVGTKGLNEFQAEIAVLTKVRHRHLVALLGFCINGNERLLVYEYMPQGTLTQHLFDWGENGCAPLTWKQRVAIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMELITGRRALDDTMPDERSHLVSWFRRVQVNKENIPKAIDQTLNPDEETMESIYKVAELAGHCTAREPYQRPDMGHAVNVLVPLVEQWKPTSHEEEDGYGIDLHMSLPQALQRWQANEGTSQMFNDTSFSQTQSSIPAKPSGFADSFDSMDCR | 934 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa2g02396 | 934 | FunFam | Receptor-like kinase TMK4 | 30 | 326 | - | - | |
Vifa2g02396 | 934 | MobiDBLite | consensus disorder prediction | 906 | 934 | - | - | |
Vifa2g02396 | 934 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 711 | 723 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa2g02396 | 934 | Pfam | Leucine rich repeat | 93 | 149 | IPR001611 | GO:0005515 | |
Vifa2g02396 | 934 | Pfam | Leucine rich repeat | 380 | 429 | IPR001611 | GO:0005515 | |
Vifa2g02396 | 934 | ProSitePatterns | Protein kinases ATP-binding region signature. | 592 | 614 | IPR017441 | GO:0005524 | |
Vifa2g02396 | 934 | Pfam | Protein tyrosine and serine/threonine kinase | 589 | 860 | IPR001245 | GO:0004672|GO:0006468 | |
Vifa2g02396 | 934 | FunFam | receptor protein kinase TMK1 | 664 | 881 | - | - | |
Vifa2g02396 | 934 | FunFam | Leucine-rich repeat receptor-like kinase | 330 | 453 | - | - | |
Vifa2g02396 | 934 | ProSiteProfiles | Leucine-rich repeat profile. | 116 | 137 | IPR001611 | GO:0005515 | |
Vifa2g02396 | 934 | SMART | serkin_6 | 586 | 866 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g02396 | 934 | MobiDBLite | consensus disorder prediction | 449 | 480 | - | - | |
Vifa2g02396 | 934 | Gene3D | Transferase(Phosphotransferase) domain 1 | 664 | 885 | - | - | |
Vifa2g02396 | 934 | Gene3D | Ribonuclease Inhibitor | 330 | 452 | IPR032675 | - | |
Vifa2g02396 | 934 | CDD | STKc_IRAK | 592 | 865 | - | - | |
Vifa2g02396 | 934 | Gene3D | Phosphorylase Kinase; domain 1 | 550 | 663 | - | - | |
Vifa2g02396 | 934 | MobiDBLite | consensus disorder prediction | 465 | 480 | - | - | |
Vifa2g02396 | 934 | SMART | LRR_typ_2 | 392 | 415 | IPR003591 | - | |
Vifa2g02396 | 934 | SMART | LRR_typ_2 | 188 | 211 | IPR003591 | - | |
Vifa2g02396 | 934 | SMART | LRR_typ_2 | 416 | 440 | IPR003591 | - | |
Vifa2g02396 | 934 | SMART | LRR_typ_2 | 114 | 137 | IPR003591 | - | |
Vifa2g02396 | 934 | MobiDBLite | consensus disorder prediction | 906 | 921 | - | - | |
Vifa2g02396 | 934 | Gene3D | Ribonuclease Inhibitor | 34 | 328 | IPR032675 | - | |
Vifa2g02396 | 934 | Pfam | Leucine rich repeat N-terminal domain | 39 | 65 | IPR013210 | - | |
Vifa2g02396 | 934 | Pfam | Leucine rich repeat N-terminal domain | 333 | 367 | IPR013210 | - | |
Vifa2g02396 | 934 | PANTHER | OSJNBA0070M12.3 PROTEIN | 17 | 934 | - | - | |
Vifa2g02396 | 934 | SUPERFAMILY | Protein kinase-like (PK-like) | 564 | 862 | IPR011009 | - | |
Vifa2g02396 | 934 | FunFam | receptor protein kinase TMK1 | 548 | 663 | - | - | |
Vifa2g02396 | 934 | SUPERFAMILY | L domain-like | 37 | 434 | - | - | |
Vifa2g02396 | 934 | ProSiteProfiles | Protein kinase domain profile. | 586 | 866 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa2g02396 | Vifa-Chr2 | 619535734 | 619539320 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa2g02396 | 70 | 862 | Receptor kinase-like Gene Family | AT5G07280 | 33.011 | 2.64e-94 | 322 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-IX | Vifa2g02396 | PK_Tyr_Ser-Thr | 1.8e-47 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa2g02396 | - | - | gmx:100781851 | 1457.2 |